nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—SLCO1B3—Methotrexate—germ cell cancer	0.218	0.369	CbGbCtD
Valsartan—SLCO1B1—Methotrexate—germ cell cancer	0.127	0.215	CbGbCtD
Valsartan—CYP2C9—Ifosfamide—germ cell cancer	0.119	0.201	CbGbCtD
Valsartan—ALB—Methotrexate—germ cell cancer	0.0695	0.118	CbGbCtD
Valsartan—CYP2C9—Cisplatin—germ cell cancer	0.0577	0.0977	CbGbCtD
Valsartan—CYP2C9—cardial valve—germ cell cancer	0.013	0.313	CbGeAlD
Valsartan—AGTR1—endothelium—germ cell cancer	0.00342	0.0825	CbGeAlD
Valsartan—AGTR1—blood vessel—germ cell cancer	0.00316	0.076	CbGeAlD
Valsartan—CYP2C9—urine—germ cell cancer	0.00281	0.0676	CbGeAlD
Valsartan—AGTR1—neck—germ cell cancer	0.00226	0.0544	CbGeAlD
Valsartan—SLCO1B3—pituitary gland—germ cell cancer	0.00206	0.0495	CbGeAlD
Valsartan—SLCO1B3—endocrine gland—germ cell cancer	0.00159	0.0384	CbGeAlD
Valsartan—AGTR1—decidua—germ cell cancer	0.00145	0.035	CbGeAlD
Valsartan—AGTR1—pituitary gland—germ cell cancer	0.00125	0.03	CbGeAlD
Valsartan—AGTR1—medulla oblongata—germ cell cancer	0.0012	0.029	CbGeAlD
Valsartan—Hepatitis—Dactinomycin—germ cell cancer	0.00115	0.00313	CcSEcCtD
Valsartan—Vertigo—Vinblastine—germ cell cancer	0.00114	0.0031	CcSEcCtD
Valsartan—Pharyngitis—Dactinomycin—germ cell cancer	0.00114	0.0031	CcSEcCtD
Valsartan—AGTR1—adrenal gland—germ cell cancer	0.00111	0.0268	CbGeAlD
Valsartan—Alopecia—Bleomycin—germ cell cancer	0.00109	0.00296	CcSEcCtD
Valsartan—Cramp muscle—Etoposide—germ cell cancer	0.00108	0.00295	CcSEcCtD
Valsartan—Haemoglobin—Ifosfamide—germ cell cancer	0.00106	0.00288	CcSEcCtD
Valsartan—Haemorrhage—Ifosfamide—germ cell cancer	0.00105	0.00286	CcSEcCtD
Valsartan—Hepatitis—Ifosfamide—germ cell cancer	0.00105	0.00286	CcSEcCtD
Valsartan—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.00105	0.00285	CcSEcCtD
Valsartan—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00104	0.00283	CcSEcCtD
Valsartan—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00104	0.00282	CcSEcCtD
Valsartan—Urethral disorder—Ifosfamide—germ cell cancer	0.00103	0.00281	CcSEcCtD
Valsartan—Vasculitis—Methotrexate—germ cell cancer	0.00102	0.00277	CcSEcCtD
Valsartan—Alopecia—Dactinomycin—germ cell cancer	0.00102	0.00276	CcSEcCtD
Valsartan—Thrombocytopenia—Vinblastine—germ cell cancer	0.00102	0.00276	CcSEcCtD
Valsartan—Renal failure—Cisplatin—germ cell cancer	0.000996	0.0027	CcSEcCtD
Valsartan—Anorexia—Vinblastine—germ cell cancer	0.000989	0.00269	CcSEcCtD
Valsartan—Cardiac disorder—Ifosfamide—germ cell cancer	0.000979	0.00266	CcSEcCtD
Valsartan—Neutropenia—Etoposide—germ cell cancer	0.000973	0.00264	CcSEcCtD
Valsartan—AGTR1—endocrine gland—germ cell cancer	0.000966	0.0233	CbGeAlD
Valsartan—Angiopathy—Ifosfamide—germ cell cancer	0.000957	0.0026	CcSEcCtD
Valsartan—AGTR1—head—germ cell cancer	0.000954	0.023	CbGeAlD
Valsartan—Immune system disorder—Ifosfamide—germ cell cancer	0.000953	0.00259	CcSEcCtD
Valsartan—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00095	0.00258	CcSEcCtD
Valsartan—Cough—Bleomycin—germ cell cancer	0.000937	0.00255	CcSEcCtD
Valsartan—Paraesthesia—Vinblastine—germ cell cancer	0.000932	0.00253	CcSEcCtD
Valsartan—Alopecia—Ifosfamide—germ cell cancer	0.000932	0.00253	CcSEcCtD
Valsartan—Infestation NOS—Etoposide—germ cell cancer	0.000928	0.00252	CcSEcCtD
Valsartan—Infestation—Etoposide—germ cell cancer	0.000928	0.00252	CcSEcCtD
Valsartan—Mental disorder—Ifosfamide—germ cell cancer	0.000924	0.00251	CcSEcCtD
Valsartan—AGTR1—testis—germ cell cancer	0.000921	0.0222	CbGeAlD
Valsartan—SLCO1B1—endocrine gland—germ cell cancer	0.000921	0.0222	CbGeAlD
Valsartan—Malnutrition—Ifosfamide—germ cell cancer	0.000918	0.00249	CcSEcCtD
Valsartan—Myalgia—Bleomycin—germ cell cancer	0.000915	0.00248	CcSEcCtD
Valsartan—Chest pain—Bleomycin—germ cell cancer	0.000915	0.00248	CcSEcCtD
Valsartan—Renal failure—Etoposide—germ cell cancer	0.000912	0.00248	CcSEcCtD
Valsartan—Decreased appetite—Vinblastine—germ cell cancer	0.000902	0.00245	CcSEcCtD
Valsartan—Urinary tract disorder—Cisplatin—germ cell cancer	0.000898	0.00244	CcSEcCtD
Valsartan—Connective tissue disorder—Cisplatin—germ cell cancer	0.000893	0.00243	CcSEcCtD
Valsartan—Urethral disorder—Cisplatin—germ cell cancer	0.000891	0.00242	CcSEcCtD
Valsartan—Constipation—Vinblastine—germ cell cancer	0.000888	0.00241	CcSEcCtD
Valsartan—Anaphylactic shock—Bleomycin—germ cell cancer	0.000877	0.00238	CcSEcCtD
Valsartan—Oedema—Bleomycin—germ cell cancer	0.000877	0.00238	CcSEcCtD
Valsartan—Infection—Bleomycin—germ cell cancer	0.000871	0.00237	CcSEcCtD
Valsartan—Vision blurred—Ifosfamide—germ cell cancer	0.000865	0.00235	CcSEcCtD
Valsartan—ALB—adrenal gland—germ cell cancer	0.000859	0.0207	CbGeAlD
Valsartan—Thrombocytopenia—Bleomycin—germ cell cancer	0.000858	0.00233	CcSEcCtD
Valsartan—Myalgia—Dactinomycin—germ cell cancer	0.000853	0.00232	CcSEcCtD
Valsartan—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000849	0.00231	CcSEcCtD
Valsartan—Cardiac disorder—Cisplatin—germ cell cancer	0.000844	0.00229	CcSEcCtD
Valsartan—Angioedema—Ifosfamide—germ cell cancer	0.000839	0.00228	CcSEcCtD
Valsartan—Anorexia—Bleomycin—germ cell cancer	0.000836	0.00227	CcSEcCtD
Valsartan—Vertigo—Ifosfamide—germ cell cancer	0.000825	0.00224	CcSEcCtD
Valsartan—Urinary tract disorder—Etoposide—germ cell cancer	0.000823	0.00223	CcSEcCtD
Valsartan—Photosensitivity—Methotrexate—germ cell cancer	0.000821	0.00223	CcSEcCtD
Valsartan—Immune system disorder—Cisplatin—germ cell cancer	0.000821	0.00223	CcSEcCtD
Valsartan—Abdominal pain—Vinblastine—germ cell cancer	0.000821	0.00223	CcSEcCtD
Valsartan—Mediastinal disorder—Cisplatin—germ cell cancer	0.000819	0.00223	CcSEcCtD
Valsartan—Hypotension—Bleomycin—germ cell cancer	0.000819	0.00223	CcSEcCtD
Valsartan—Oedema—Dactinomycin—germ cell cancer	0.000818	0.00222	CcSEcCtD
Valsartan—Urethral disorder—Etoposide—germ cell cancer	0.000817	0.00222	CcSEcCtD
Valsartan—Infection—Dactinomycin—germ cell cancer	0.000812	0.00221	CcSEcCtD
Valsartan—Palpitations—Ifosfamide—germ cell cancer	0.000811	0.0022	CcSEcCtD
Valsartan—Alopecia—Cisplatin—germ cell cancer	0.000803	0.00218	CcSEcCtD
Valsartan—Cough—Ifosfamide—germ cell cancer	0.000801	0.00218	CcSEcCtD
Valsartan—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000801	0.00217	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000799	0.00217	CcSEcCtD
Valsartan—Malnutrition—Cisplatin—germ cell cancer	0.000791	0.00215	CcSEcCtD
Valsartan—Paraesthesia—Bleomycin—germ cell cancer	0.000787	0.00214	CcSEcCtD
Valsartan—Dyspnoea—Bleomycin—germ cell cancer	0.000782	0.00212	CcSEcCtD
Valsartan—Arthralgia—Ifosfamide—germ cell cancer	0.000782	0.00212	CcSEcCtD
Valsartan—Myalgia—Ifosfamide—germ cell cancer	0.000782	0.00212	CcSEcCtD
Valsartan—Chest pain—Ifosfamide—germ cell cancer	0.000782	0.00212	CcSEcCtD
Valsartan—Renal failure acute—Methotrexate—germ cell cancer	0.000781	0.00212	CcSEcCtD
Valsartan—Flatulence—Cisplatin—germ cell cancer	0.00078	0.00212	CcSEcCtD
Valsartan—Anorexia—Dactinomycin—germ cell cancer	0.000779	0.00212	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000776	0.00211	CcSEcCtD
Valsartan—Cardiac disorder—Etoposide—germ cell cancer	0.000773	0.0021	CcSEcCtD
Valsartan—Hypersensitivity—Vinblastine—germ cell cancer	0.000765	0.00208	CcSEcCtD
Valsartan—Decreased appetite—Bleomycin—germ cell cancer	0.000762	0.00207	CcSEcCtD
Valsartan—Muscle spasms—Cisplatin—germ cell cancer	0.000761	0.00207	CcSEcCtD
Valsartan—Angiopathy—Etoposide—germ cell cancer	0.000756	0.00205	CcSEcCtD
Valsartan—Immune system disorder—Etoposide—germ cell cancer	0.000752	0.00204	CcSEcCtD
Valsartan—Mediastinal disorder—Etoposide—germ cell cancer	0.000751	0.00204	CcSEcCtD
Valsartan—Oedema—Ifosfamide—germ cell cancer	0.000749	0.00204	CcSEcCtD
Valsartan—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000749	0.00204	CcSEcCtD
Valsartan—Vision blurred—Cisplatin—germ cell cancer	0.000746	0.00203	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000745	0.00202	CcSEcCtD
Valsartan—Asthenia—Vinblastine—germ cell cancer	0.000745	0.00202	CcSEcCtD
Valsartan—Infection—Ifosfamide—germ cell cancer	0.000744	0.00202	CcSEcCtD
Valsartan—Alopecia—Etoposide—germ cell cancer	0.000736	0.002	CcSEcCtD
Valsartan—Nervous system disorder—Ifosfamide—germ cell cancer	0.000735	0.002	CcSEcCtD
Valsartan—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000734	0.00199	CcSEcCtD
Valsartan—Skin disorder—Ifosfamide—germ cell cancer	0.000728	0.00198	CcSEcCtD
Valsartan—Anorexia—Ifosfamide—germ cell cancer	0.000714	0.00194	CcSEcCtD
Valsartan—Decreased appetite—Dactinomycin—germ cell cancer	0.000711	0.00193	CcSEcCtD
Valsartan—ALB—testis—germ cell cancer	0.000711	0.0171	CbGeAlD
Valsartan—Diarrhoea—Vinblastine—germ cell cancer	0.00071	0.00193	CcSEcCtD
Valsartan—Dysgeusia—Etoposide—germ cell cancer	0.00071	0.00193	CcSEcCtD
Valsartan—Fatigue—Dactinomycin—germ cell cancer	0.000705	0.00192	CcSEcCtD
Valsartan—Back pain—Etoposide—germ cell cancer	0.000701	0.00191	CcSEcCtD
Valsartan—Hypotension—Ifosfamide—germ cell cancer	0.0007	0.0019	CcSEcCtD
Valsartan—Muscle spasms—Etoposide—germ cell cancer	0.000697	0.00189	CcSEcCtD
Valsartan—Urticaria—Bleomycin—germ cell cancer	0.000696	0.00189	CcSEcCtD
Valsartan—AGTR1—brain—germ cell cancer	0.000691	0.0166	CbGeAlD
Valsartan—Dizziness—Vinblastine—germ cell cancer	0.000686	0.00186	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000683	0.00185	CcSEcCtD
Valsartan—Myalgia—Cisplatin—germ cell cancer	0.000674	0.00183	CcSEcCtD
Valsartan—Paraesthesia—Ifosfamide—germ cell cancer	0.000673	0.00183	CcSEcCtD
Valsartan—Anxiety—Cisplatin—germ cell cancer	0.000672	0.00182	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000669	0.00182	CcSEcCtD
Valsartan—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000669	0.00182	CcSEcCtD
Valsartan—Dyspnoea—Ifosfamide—germ cell cancer	0.000668	0.00181	CcSEcCtD
Valsartan—AGTR1—lymph node—germ cell cancer	0.000668	0.0161	CbGeAlD
Valsartan—Somnolence—Ifosfamide—germ cell cancer	0.000666	0.00181	CcSEcCtD
Valsartan—Vomiting—Vinblastine—germ cell cancer	0.00066	0.00179	CcSEcCtD
Valsartan—Vertigo—Etoposide—germ cell cancer	0.000651	0.00177	CcSEcCtD
Valsartan—Decreased appetite—Ifosfamide—germ cell cancer	0.000651	0.00177	CcSEcCtD
Valsartan—Headache—Vinblastine—germ cell cancer	0.00065	0.00177	CcSEcCtD
Valsartan—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000647	0.00176	CcSEcCtD
Valsartan—Abdominal pain—Dactinomycin—germ cell cancer	0.000646	0.00176	CcSEcCtD
Valsartan—Fatigue—Ifosfamide—germ cell cancer	0.000646	0.00175	CcSEcCtD
Valsartan—Anaphylactic shock—Cisplatin—germ cell cancer	0.000646	0.00175	CcSEcCtD
Valsartan—Oedema—Cisplatin—germ cell cancer	0.000646	0.00175	CcSEcCtD
Valsartan—Hypersensitivity—Bleomycin—germ cell cancer	0.000646	0.00175	CcSEcCtD
Valsartan—Infection—Cisplatin—germ cell cancer	0.000642	0.00174	CcSEcCtD
Valsartan—Constipation—Ifosfamide—germ cell cancer	0.000641	0.00174	CcSEcCtD
Valsartan—Loss of consciousness—Etoposide—germ cell cancer	0.000637	0.00173	CcSEcCtD
Valsartan—Nervous system disorder—Cisplatin—germ cell cancer	0.000633	0.00172	CcSEcCtD
Valsartan—Cough—Etoposide—germ cell cancer	0.000633	0.00172	CcSEcCtD
Valsartan—Thrombocytopenia—Cisplatin—germ cell cancer	0.000632	0.00172	CcSEcCtD
Valsartan—Asthenia—Bleomycin—germ cell cancer	0.000629	0.00171	CcSEcCtD
Valsartan—Skin disorder—Cisplatin—germ cell cancer	0.000627	0.0017	CcSEcCtD
Valsartan—Pruritus—Bleomycin—germ cell cancer	0.00062	0.00169	CcSEcCtD
Valsartan—Chest pain—Etoposide—germ cell cancer	0.000617	0.00168	CcSEcCtD
Valsartan—Nausea—Vinblastine—germ cell cancer	0.000617	0.00167	CcSEcCtD
Valsartan—Anorexia—Cisplatin—germ cell cancer	0.000616	0.00167	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000613	0.00167	CcSEcCtD
Valsartan—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000613	0.00166	CcSEcCtD
Valsartan—Hypotension—Cisplatin—germ cell cancer	0.000604	0.00164	CcSEcCtD
Valsartan—Hypersensitivity—Dactinomycin—germ cell cancer	0.000602	0.00164	CcSEcCtD
Valsartan—Urticaria—Ifosfamide—germ cell cancer	0.000595	0.00162	CcSEcCtD
Valsartan—Abdominal pain—Ifosfamide—germ cell cancer	0.000592	0.00161	CcSEcCtD
Valsartan—Anaphylactic shock—Etoposide—germ cell cancer	0.000592	0.00161	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000589	0.0016	CcSEcCtD
Valsartan—Infection—Etoposide—germ cell cancer	0.000588	0.0016	CcSEcCtD
Valsartan—Asthenia—Dactinomycin—germ cell cancer	0.000587	0.00159	CcSEcCtD
Valsartan—Neutropenia—Methotrexate—germ cell cancer	0.000583	0.00158	CcSEcCtD
Valsartan—Paraesthesia—Cisplatin—germ cell cancer	0.00058	0.00158	CcSEcCtD
Valsartan—Thrombocytopenia—Etoposide—germ cell cancer	0.000579	0.00157	CcSEcCtD
Valsartan—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000579	0.00157	CcSEcCtD
Valsartan—Dyspnoea—Cisplatin—germ cell cancer	0.000576	0.00156	CcSEcCtD
Valsartan—Skin disorder—Etoposide—germ cell cancer	0.000575	0.00156	CcSEcCtD
Valsartan—Erectile dysfunction—Methotrexate—germ cell cancer	0.000574	0.00156	CcSEcCtD
Valsartan—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000569	0.00155	CcSEcCtD
Valsartan—Anorexia—Etoposide—germ cell cancer	0.000564	0.00153	CcSEcCtD
Valsartan—Decreased appetite—Cisplatin—germ cell cancer	0.000562	0.00153	CcSEcCtD
Valsartan—Diarrhoea—Dactinomycin—germ cell cancer	0.000559	0.00152	CcSEcCtD
Valsartan—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000558	0.00151	CcSEcCtD
Valsartan—Vomiting—Bleomycin—germ cell cancer	0.000557	0.00151	CcSEcCtD
Valsartan—Infestation NOS—Methotrexate—germ cell cancer	0.000556	0.00151	CcSEcCtD
Valsartan—Infestation—Methotrexate—germ cell cancer	0.000556	0.00151	CcSEcCtD
Valsartan—Hypotension—Etoposide—germ cell cancer	0.000553	0.0015	CcSEcCtD
Valsartan—Rash—Bleomycin—germ cell cancer	0.000553	0.0015	CcSEcCtD
Valsartan—Dermatitis—Bleomycin—germ cell cancer	0.000552	0.0015	CcSEcCtD
Valsartan—Hypersensitivity—Ifosfamide—germ cell cancer	0.000552	0.0015	CcSEcCtD
Valsartan—Renal failure—Methotrexate—germ cell cancer	0.000546	0.00148	CcSEcCtD
Valsartan—Asthenia—Ifosfamide—germ cell cancer	0.000538	0.00146	CcSEcCtD
Valsartan—ALB—brain—germ cell cancer	0.000533	0.0128	CbGeAlD
Valsartan—Paraesthesia—Etoposide—germ cell cancer	0.000531	0.00144	CcSEcCtD
Valsartan—Pruritus—Ifosfamide—germ cell cancer	0.00053	0.00144	CcSEcCtD
Valsartan—Dyspnoea—Etoposide—germ cell cancer	0.000528	0.00143	CcSEcCtD
Valsartan—Somnolence—Etoposide—germ cell cancer	0.000526	0.00143	CcSEcCtD
Valsartan—Epistaxis—Methotrexate—germ cell cancer	0.000524	0.00142	CcSEcCtD
Valsartan—Nausea—Bleomycin—germ cell cancer	0.000521	0.00141	CcSEcCtD
Valsartan—Vomiting—Dactinomycin—germ cell cancer	0.00052	0.00141	CcSEcCtD
Valsartan—Rash—Dactinomycin—germ cell cancer	0.000516	0.0014	CcSEcCtD
Valsartan—ALB—lymph node—germ cell cancer	0.000515	0.0124	CbGeAlD
Valsartan—Decreased appetite—Etoposide—germ cell cancer	0.000514	0.0014	CcSEcCtD
Valsartan—Diarrhoea—Ifosfamide—germ cell cancer	0.000513	0.00139	CcSEcCtD
Valsartan—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000511	0.00139	CcSEcCtD
Valsartan—Fatigue—Etoposide—germ cell cancer	0.00051	0.00139	CcSEcCtD
Valsartan—Constipation—Etoposide—germ cell cancer	0.000506	0.00137	CcSEcCtD
Valsartan—Haemoglobin—Methotrexate—germ cell cancer	0.000501	0.00136	CcSEcCtD
Valsartan—Hepatitis—Methotrexate—germ cell cancer	0.000499	0.00136	CcSEcCtD
Valsartan—Haemorrhage—Methotrexate—germ cell cancer	0.000499	0.00136	CcSEcCtD
Valsartan—Dizziness—Ifosfamide—germ cell cancer	0.000495	0.00135	CcSEcCtD
Valsartan—Pharyngitis—Methotrexate—germ cell cancer	0.000495	0.00135	CcSEcCtD
Valsartan—Urinary tract disorder—Methotrexate—germ cell cancer	0.000493	0.00134	CcSEcCtD
Valsartan—Urethral disorder—Methotrexate—germ cell cancer	0.000489	0.00133	CcSEcCtD
Valsartan—Nausea—Dactinomycin—germ cell cancer	0.000486	0.00132	CcSEcCtD
Valsartan—Gastrointestinal pain—Etoposide—germ cell cancer	0.000484	0.00131	CcSEcCtD
Valsartan—Vomiting—Ifosfamide—germ cell cancer	0.000476	0.00129	CcSEcCtD
Valsartan—Hypersensitivity—Cisplatin—germ cell cancer	0.000476	0.00129	CcSEcCtD
Valsartan—Rash—Ifosfamide—germ cell cancer	0.000472	0.00128	CcSEcCtD
Valsartan—Dermatitis—Ifosfamide—germ cell cancer	0.000472	0.00128	CcSEcCtD
Valsartan—Urticaria—Etoposide—germ cell cancer	0.00047	0.00128	CcSEcCtD
Valsartan—Abdominal pain—Etoposide—germ cell cancer	0.000468	0.00127	CcSEcCtD
Valsartan—CYP2C9—endocrine gland—germ cell cancer	0.000465	0.0112	CbGeAlD
Valsartan—Asthenia—Cisplatin—germ cell cancer	0.000463	0.00126	CcSEcCtD
Valsartan—Cardiac disorder—Methotrexate—germ cell cancer	0.000463	0.00126	CcSEcCtD
Valsartan—Angiopathy—Methotrexate—germ cell cancer	0.000453	0.00123	CcSEcCtD
Valsartan—Immune system disorder—Methotrexate—germ cell cancer	0.000451	0.00122	CcSEcCtD
Valsartan—Mediastinal disorder—Methotrexate—germ cell cancer	0.00045	0.00122	CcSEcCtD
Valsartan—Nausea—Ifosfamide—germ cell cancer	0.000445	0.00121	CcSEcCtD
Valsartan—Diarrhoea—Cisplatin—germ cell cancer	0.000442	0.0012	CcSEcCtD
Valsartan—Alopecia—Methotrexate—germ cell cancer	0.000441	0.0012	CcSEcCtD
Valsartan—Mental disorder—Methotrexate—germ cell cancer	0.000437	0.00119	CcSEcCtD
Valsartan—Hypersensitivity—Etoposide—germ cell cancer	0.000436	0.00118	CcSEcCtD
Valsartan—Malnutrition—Methotrexate—germ cell cancer	0.000434	0.00118	CcSEcCtD
Valsartan—Dysgeusia—Methotrexate—germ cell cancer	0.000425	0.00116	CcSEcCtD
Valsartan—Asthenia—Etoposide—germ cell cancer	0.000425	0.00115	CcSEcCtD
Valsartan—Back pain—Methotrexate—germ cell cancer	0.00042	0.00114	CcSEcCtD
Valsartan—Pruritus—Etoposide—germ cell cancer	0.000419	0.00114	CcSEcCtD
Valsartan—Vomiting—Cisplatin—germ cell cancer	0.000411	0.00112	CcSEcCtD
Valsartan—Vision blurred—Methotrexate—germ cell cancer	0.000409	0.00111	CcSEcCtD
Valsartan—Rash—Cisplatin—germ cell cancer	0.000407	0.00111	CcSEcCtD
Valsartan—Dermatitis—Cisplatin—germ cell cancer	0.000407	0.00111	CcSEcCtD
Valsartan—Diarrhoea—Etoposide—germ cell cancer	0.000405	0.0011	CcSEcCtD
Valsartan—Dizziness—Etoposide—germ cell cancer	0.000391	0.00106	CcSEcCtD
Valsartan—Vertigo—Methotrexate—germ cell cancer	0.00039	0.00106	CcSEcCtD
Valsartan—Nausea—Cisplatin—germ cell cancer	0.000384	0.00104	CcSEcCtD
Valsartan—Cough—Methotrexate—germ cell cancer	0.000379	0.00103	CcSEcCtD
Valsartan—Vomiting—Etoposide—germ cell cancer	0.000376	0.00102	CcSEcCtD
Valsartan—Rash—Etoposide—germ cell cancer	0.000373	0.00101	CcSEcCtD
Valsartan—Dermatitis—Etoposide—germ cell cancer	0.000373	0.00101	CcSEcCtD
Valsartan—Headache—Etoposide—germ cell cancer	0.000371	0.00101	CcSEcCtD
Valsartan—Myalgia—Methotrexate—germ cell cancer	0.00037	0.001	CcSEcCtD
Valsartan—Arthralgia—Methotrexate—germ cell cancer	0.00037	0.001	CcSEcCtD
Valsartan—Chest pain—Methotrexate—germ cell cancer	0.00037	0.001	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000367	0.000998	CcSEcCtD
Valsartan—Anaphylactic shock—Methotrexate—germ cell cancer	0.000354	0.000963	CcSEcCtD
Valsartan—Infection—Methotrexate—germ cell cancer	0.000352	0.000957	CcSEcCtD
Valsartan—Nausea—Etoposide—germ cell cancer	0.000352	0.000955	CcSEcCtD
Valsartan—Nervous system disorder—Methotrexate—germ cell cancer	0.000348	0.000944	CcSEcCtD
Valsartan—Thrombocytopenia—Methotrexate—germ cell cancer	0.000347	0.000943	CcSEcCtD
Valsartan—Skin disorder—Methotrexate—germ cell cancer	0.000344	0.000935	CcSEcCtD
Valsartan—Anorexia—Methotrexate—germ cell cancer	0.000338	0.000918	CcSEcCtD
Valsartan—Hypotension—Methotrexate—germ cell cancer	0.000331	0.0009	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000323	0.000877	CcSEcCtD
Valsartan—Insomnia—Methotrexate—germ cell cancer	0.000321	0.000871	CcSEcCtD
Valsartan—Paraesthesia—Methotrexate—germ cell cancer	0.000318	0.000865	CcSEcCtD
Valsartan—Dyspnoea—Methotrexate—germ cell cancer	0.000316	0.000858	CcSEcCtD
Valsartan—Somnolence—Methotrexate—germ cell cancer	0.000315	0.000856	CcSEcCtD
Valsartan—Dyspepsia—Methotrexate—germ cell cancer	0.000312	0.000848	CcSEcCtD
Valsartan—Decreased appetite—Methotrexate—germ cell cancer	0.000308	0.000837	CcSEcCtD
Valsartan—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000306	0.000831	CcSEcCtD
Valsartan—Fatigue—Methotrexate—germ cell cancer	0.000306	0.00083	CcSEcCtD
Valsartan—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00029	0.000787	CcSEcCtD
Valsartan—Urticaria—Methotrexate—germ cell cancer	0.000282	0.000765	CcSEcCtD
Valsartan—Abdominal pain—Methotrexate—germ cell cancer	0.00028	0.000761	CcSEcCtD
Valsartan—Hypersensitivity—Methotrexate—germ cell cancer	0.000261	0.000709	CcSEcCtD
Valsartan—Asthenia—Methotrexate—germ cell cancer	0.000254	0.000691	CcSEcCtD
Valsartan—Pruritus—Methotrexate—germ cell cancer	0.000251	0.000681	CcSEcCtD
Valsartan—Diarrhoea—Methotrexate—germ cell cancer	0.000243	0.000659	CcSEcCtD
Valsartan—Dizziness—Methotrexate—germ cell cancer	0.000234	0.000637	CcSEcCtD
Valsartan—Vomiting—Methotrexate—germ cell cancer	0.000225	0.000612	CcSEcCtD
Valsartan—Rash—Methotrexate—germ cell cancer	0.000224	0.000607	CcSEcCtD
Valsartan—Dermatitis—Methotrexate—germ cell cancer	0.000223	0.000607	CcSEcCtD
Valsartan—Headache—Methotrexate—germ cell cancer	0.000222	0.000603	CcSEcCtD
Valsartan—Nausea—Methotrexate—germ cell cancer	0.000211	0.000572	CcSEcCtD
